港股異動 | 晨鳴紙業(1812.HK)跌5.52% 第四季度淨利潤同比減118.38%
格隆匯3月31日丨晨鳴紙業(1812.HK)跌5.52%,報3.25港元,總市值96億港元。該公司昨日發佈財報,公司主營收入330.2億元,同比上升7.43%;歸母淨利潤20.66億元,同比上升20.65%;扣非淨利潤17.44億元,同比上升55.83%;其中2021年第四季度,公司單季度主營收入72.58億元,同比下降16.22%;單季度歸母淨利潤-11681.62萬元,同比下降118.38%;單季度扣非淨利潤-21142.23萬元,同比下降135.96%;負債率72.78%,投資收益-6957.83萬元,財務費用23.87億元,毛利率23.61%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.